News by Kowa 1

Pyran continues its trajectory toward building a commercial plant for 1,5-pentanediol (PDO), its high-performance, bio-based diol product. The plant is being built after closing the latest round of fundraising, which includes a $3 million investment from the lead investor, Kowa. Pyran’s Series B equity funding round raised over $5 million with investor support from Kowa and long-term investors such as the venture arm of Wisconsin Alumni Research Foundation (WARF) and Arosa Capital.